Integrate multiple modes of biology from a single sample in a single experiment to provide transformative insights into health and disease.
Read the latest research paper featuring 6-base sequencing in Nature Structural & Molecular Biology.
Current technologies are unable to reliably resolve both genetic and epigenetic sequences at low sample input and miss important information. biomodal’s duet multiomics solution evoC gives you access to the 6-base genome – all four canonical bases and distinguishes 5‑methylcytosine (5mC) and 5‑hydroxymethylcytosine (5hmC) – from a single 5ng DNA sample, in a single experiment, with high accuracy.
Combined epigenetic and genetic analysis in a single sequencing run lets you access the most critical information from your DNA samples.
Better characterise liquid biopsy and genomic DNA samples of early stage cancer for diagnostic and therapy development.
Combined data reveals the role of methylation in neurodegeneration.
Pinpoint epigenetic changes that determine patterns of disease and health throughout a lifespan.
Improved DNA-based diagnostics with the ability to see disease-relevant changes from low input samples
Detect minute epigenetic changes to better understand maternal and foetal health.
A true 6-base genome that distinguishes 5mC and 5hmC together with all four canonical bases to measure multiple modes of biology
Assess all four canonical bases plus modified cytosine
modality XPLR is an accessible and scalable software tool designed for scientists and translational researchers to uncover disease-relevant epigenetic signatures, link methylation to gene regulation, and support biomarker discovery—empowering you to identify, classify, and monitor disease.
biomodal’s Certified Service Provider (CSP) program partners with organisations around the globe to meet the increasing demand for its novel duet multiomics solutions.
Functional genomics is a crucial part of research and development within healthcare because it closes the gap between genetic information and biological function
We can help you reveal new data and multimodal insights from your research.
